adenosine has been researched along with Neurodegenerative Diseases in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.06) | 18.2507 |
| 2000's | 9 (27.27) | 29.6817 |
| 2010's | 11 (33.33) | 24.3611 |
| 2020's | 11 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CP; Chern, Y; Lin, CY; Wu, KC | 1 |
| Allen, SP; George, JG; Hall, B | 1 |
| Boussadia, Z; Chiodi, V; Martire, A; Pazienti, A | 1 |
| Bekas, N; Christoforidou, G; Dafou, D; Kanata, E; Karagianni, K; Pettas, S; Sklaviadis, T; Xanthopoulos, K | 1 |
| Duarte-Silva, E; Hartung, HP; Meuth, SG; Oliveira-Giacomelli, Á; Peixoto, CA; Ulrich, H | 1 |
| Karati, D; Mukherjee, S; Roy, S | 1 |
| Andrejew, R; Glaser, T; Godoy, M; Granato, A; Oliveira-Giacomelli, Á; Ribeiro, D; Ulrich, H | 1 |
| Allen, EG; Jin, P; Shafik, AM | 1 |
| Costa Cruz, PH; Kawahara, Y | 1 |
| Aschner, M; Guo, Z; Li, H; Li, Y; Tang, J; Wang, YL; Wu, S; Yu, G; Zheng, C; Zheng, F | 1 |
| Allen, EG; Dai, Q; Duan, R; Guo, Z; He, C; Jin, P; Kang, Y; Li, Y; Pajdzik, K; Shafik, AM; Wu, H; Yao, B; Zhang, F | 1 |
| Griñán-Ferré, C; Izquierdo, V; Pallàs, M; Palomera-Ávalos, V | 1 |
| Chen, J; Duan, S; Gao, Z; Ge, Q; Guo, F; Guo, Z; Hu, Y; Lou, H; Mai, W; Meng, F; Zhang, B; Zhang, Z | 1 |
| Chellappan, DK; Choudhury, H; Gorain, B; Pandey, M; Sengupta, P | 1 |
| Allen, EG; Armstrong, MJ; Jin, P; Jin, Y | 1 |
| Burnstock, G | 1 |
| Das, B; Maity, A | 1 |
| Borea, PA; Gessi, S; Merighi, S; Varani, K; Vincenzi, F | 1 |
| Boison, D; Chen, JF; Fredholm, BB | 1 |
| Ariga, H; Kitamura, Y; Taira, T; Takata, K; Taniguchi, T; Yamane, K; Yanagida, T; Yanagisawa, D | 1 |
| Sereda, MJ | 1 |
| Lopes, LV; Ribeiro, JA; Sebastião, AM | 1 |
| Galeano, F; Gallo, A; Pesole, G; Picardi, E; Tomaselli, S | 1 |
| de Mendonca, A; Ribeiro, JA; Sebastiao, AM | 1 |
| Pandit, MK; Parihar, MS | 1 |
| Baker, DJ; Scaramuzzi, RJ | 1 |
| Biber, K; Boddeke, HW; Wittendorp, MC | 1 |
| Domenici, MR; Frank, C; Grieco, R; Martire, A; Pepponi, R; Pintor, A; Popoli, P; Potenza, RL; Tebano, MT | 1 |
| Stone, TW | 1 |
| Darlington, LG; Forrest, CM; Mackay, GM; Stone, TW; Stoy, N | 1 |
| Camarasa, J; Camins, A; Escubedo, E; Guitart, L; Jiménez, A; Pallàs, M; Pubill, D; Sureda, FX | 1 |
| Fricker, J | 1 |
| Abbracchio, MP; Cattabeni, F | 1 |
19 review(s) available for adenosine and Neurodegenerative Diseases
| Article | Year |
|---|---|
Emerging roles of dysregulated adenosine homeostasis in brain disorders with a specific focus on neurodegenerative diseases.
Topics: Adenosine; Brain; Homeostasis; Humans; Neurodegenerative Diseases; Proteins | 2021 |
Adenosine deaminase, not immune to a mechanistic rethink in central nervous system disorders?
Topics: Adenosine; Adenosine Deaminase; Amyotrophic Lateral Sclerosis; Brain; Humans; Neurodegenerative Diseases | 2022 |
A Systematic Review of Common and Brain-Disease-Specific RNA Editing Alterations Providing Novel Insights into Neurological and Neurodegenerative Disease Manifestations.
Topics: Adenosine; Adenosine Deaminase; Animals; Brain; Brain Diseases; Mammals; Neurodegenerative Diseases; RNA; RNA Editing | 2022 |
The adenosinergic signaling in the pathogenesis and treatment of multiple sclerosis.
Topics: Adenosine; Adenosine Deaminase; Apyrase; Humans; Multiple Sclerosis; Neurodegenerative Diseases; Receptors, Purinergic P1; Signal Transduction | 2022 |
Molecular and Structural Insight into Adenosine A
Topics: Adenosine; Humans; Ligands; Neurodegenerative Diseases; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2A; Receptors, Purinergic P1 | 2023 |
Targeting Purinergic Signaling and Cell Therapy in Cardiovascular and Neurodegenerative Diseases.
Topics: Adenosine; Adenosine Triphosphate; Cardiovascular Diseases; Humans; Neurodegenerative Diseases; Purinergic Antagonists; Receptors, Purinergic; Signal Transduction; Stem Cell Transplantation | 2019 |
Dynamic N6-methyladenosine RNA methylation in brain and diseases.
Topics: Adenosine; Brain; Histone Code; Humans; Mental Disorders; Methylation; Neurodegenerative Diseases; Neurogenesis; RNA, Messenger | 2020 |
RNA Editing in Neurological and Neurodegenerative Disorders.
Topics: Adenosine; Amyotrophic Lateral Sclerosis; Animals; Epilepsy; Humans; Inosine; Nervous System Diseases; Neurodegenerative Diseases; Phenotype; RNA Editing | 2021 |
Adenosine Receptors in Modulation of Central Nervous System Disorders.
Topics: Adenosine; Central Nervous System; Central Nervous System Diseases; Humans; Neurodegenerative Diseases; Receptors, Purinergic P1; Signal Transduction | 2019 |
Diverse and dynamic DNA modifications in brain and diseases.
Topics: Adenosine; Alzheimer Disease; Animals; Ataxia; Brain; Chromatin; Cytosine; DNA; DNA Methylation; Epigenesis, Genetic; Histones; Humans; Mice; Neurodegenerative Diseases; Parkinson Disease | 2019 |
An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
Topics: Adenosine; Animals; Brain; Brain Ischemia; Humans; Nerve Regeneration; Neural Stem Cells; Neurodegenerative Diseases; Neurons; Purines; Pyrimidines; Receptors, Purinergic; Receptors, Purinergic P2X; Receptors, Purinergic P2Y; Signal Transduction; Stroke | 2016 |
N6-methyladenosine modification in mRNA: machinery, function and implications for health and diseases.
Topics: Adenosine; Cell Differentiation; Eukaryotic Cells; Humans; Methylation; Methyltransferases; Neoplasms; Neurodegenerative Diseases; Oxidoreductases, N-Demethylating; RNA Splicing; RNA, Long Noncoding; RNA, Messenger; Signal Transduction; Transcription, Genetic | 2016 |
Pathological overproduction: the bad side of adenosine.
Topics: Adenosine; Animals; Humans; Neurodegenerative Diseases | 2017 |
Adenosine signaling and function in glial cells.
Topics: Adenosine; Anticonvulsants; Apoptosis; Humans; Neurodegenerative Diseases; Neuroglia; Neurons; Receptors, Purinergic P1; Signal Transduction | 2010 |
Adenosine and related drugs in brain diseases: present and future in clinical trials.
Topics: Adenosine; Animals; Astrocytes; Brain; Brain Diseases; Clinical Trials as Topic; Cognition; Forecasting; Humans; Memory; Mice; Mice, Knockout; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Neurotransmitter Agents; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Receptor, Adenosine A1; Receptor, Adenosine A2A; Schizophrenia; Substance-Related Disorders | 2011 |
Participation of adenosine receptors in neuroprotection.
Topics: Adenosine; Drug Design; Humans; Mental Processes; Nervous System Diseases; Neurodegenerative Diseases; Neuronal Plasticity; Receptors, Purinergic P1; Synaptic Transmission | 2003 |
Possible therapeutic benefits of adenosine-potentiating drugs in reducing age-related degenerative disease in dogs and cats.
Topics: Adenosine; Aging; Animals; Cat Diseases; Cats; Dog Diseases; Dogs; Neurodegenerative Diseases; Neuroprotective Agents | 2003 |
Adenosine, neurodegeneration and neuroprotection.
Topics: Adenosine; Animals; Cell Survival; Drug Interactions; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Purinergic Agonists; Purinergic Antagonists; Reactive Oxygen Species; Receptors, Purinergic | 2005 |
Tryptophan, adenosine, neurodegeneration and neuroprotection.
Topics: Adenosine; Animals; Hepatic Encephalopathy; Humans; Kynurenine; NAD; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Quinolinic Acid; Receptors, N-Methyl-D-Aspartate; Receptors, Purinergic P1; Tryptophan | 2007 |
14 other study(ies) available for adenosine and Neurodegenerative Diseases
| Article | Year |
|---|---|
A major role for adenosine A
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Astrocytes; Humans; Neurodegenerative Diseases; Neurons; Receptor, Adenosine A2A | 2022 |
Global N6-methyladenosine profiling of cobalt-exposed cortex and human neuroblastoma H4 cells presents epitranscriptomics alterations in neurodegenerative disease-associated genes.
Topics: Adenosine; Animals; Cobalt; Gene Expression Regulation; Humans; Learning; Memory; Mice; Mice, Inbred C57BL; Neuroblastoma; Neurodegenerative Diseases; RNA | 2020 |
N6-methyladenosine dynamics in neurodevelopment and aging, and its potential role in Alzheimer's disease.
Topics: Adenosine; Aging; Alzheimer Disease; Animals; Brain; Disease Models, Animal; Drosophila; Drosophila Proteins; Humans; Methylation; Methyltransferases; Mice; Neurodegenerative Diseases; RNA Stability | 2021 |
Resveratrol Supplementation Attenuates Cognitive and Molecular Alterations under Maternal High-Fat Diet Intake: Epigenetic Inheritance over Generations.
Topics: Adenosine; Animals; Body Weight; Brain; Cognition; Diet, High-Fat; Dietary Supplements; DNA Methylation; Epigenesis, Genetic; Epigenomics; Female; Inflammation; Leptin; Male; Maternal Exposure; Maze Learning; Methylation; Mice; Neurodegenerative Diseases; Neuronal Plasticity; Obesity; Pregnancy; Pregnancy, Animal; Prenatal Exposure Delayed Effects; Resveratrol; Triglycerides | 2021 |
CD73-derived adenosine controls inflammation and neurodegeneration by modulating dopamine signalling.
Topics: 5'-Nucleotidase; Adenosine; Animals; Disease Models, Animal; Dopamine; Dopaminergic Neurons; GPI-Linked Proteins; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; Neurodegenerative Diseases; Parkinson Disease; Receptor, Adenosine A2A; Signal Transduction | 2019 |
Oxidative neurodegeneration is prevented by UCP0045037, an allosteric modulator for the reduced form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7.
Topics: Adenosine; Allosteric Regulation; Animals; Apoptosis; Brain; Cell Line; Humans; Hydrogen Peroxide; Intracellular Signaling Peptides and Proteins; Neurodegenerative Diseases; Neuroprotective Agents; Oncogene Proteins; Oxidation-Reduction; Oxidative Stress; Protein Deglycase DJ-1; Rats; RNA Interference; RNA, Small Interfering | 2009 |
Purines 2010: Adenine Nucleosides and Nucleotides in Biomedicine.
Topics: Adenine Nucleotides; Adenosine; Anemia, Sickle Cell; Bone and Bones; Cystic Fibrosis; Drug Design; Drugs, Investigational; Humans; Neoplasms; Neurodegenerative Diseases; Pain; Pulmonary Fibrosis; Receptors, Purinergic; Signal Transduction | 2010 |
A novel computational strategy to identify A-to-I RNA editing sites by RNA-Seq data: de novo detection in human spinal cord tissue.
Topics: Adenosine; Algorithms; Brain; Computational Biology; Databases, Genetic; Exome; Gene Expression Regulation; Genome, Human; Genomics; Homeostasis; Humans; Inosine; Neurodegenerative Diseases; Reproducibility of Results; RNA Editing; Software; Spinal Cord; Transcriptome | 2012 |
Free radical induced increase in protein carbonyl is attenuated by low dose of adenosine in hippocampus and mid brain: implication in neurodegenerative disorders.
Topics: Adenosine; Animals; Dose-Response Relationship, Drug; Free Radicals; Glutathione; Hippocampus; Male; Mesencephalon; Mice; Neurodegenerative Diseases; Neurons; Proteins; tert-Butylhydroperoxide | 2003 |
Adenosine A3 receptor-induced CCL2 synthesis in cultured mouse astrocytes.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Agonists; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Animals; Animals, Newborn; Astrocytes; Brain Chemistry; Calcium Signaling; Cell Culture Techniques; Chemokine CCL2; Mice; Microglia; Nerve Growth Factors; Neurodegenerative Diseases; Neuroprotective Agents; Pertussis Toxin; Protein Biosynthesis; Proteins; Receptor, Adenosine A1; Receptor, Adenosine A3; Receptors, Adenosine A2; RNA, Messenger | 2004 |
Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre- and postsynaptic sites in the rat striatum.
Topics: 4-Aminopyridine; Adenosine; Adenosine A2 Receptor Antagonists; Animals; Calcium; Corpus Striatum; Dose-Response Relationship, Drug; Glutamic Acid; In Vitro Techniques; L-Lactate Dehydrogenase; Male; Models, Biological; N-Methylaspartate; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Neurotoxins; Phenethylamines; Pyrimidines; Quinolinic Acid; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptors, N-Methyl-D-Aspartate; Synaptic Membranes; Synaptic Transmission; Triazines; Triazoles | 2004 |
Microgliosis and down-regulation of adenosine transporter induced by methamphetamine in rats.
Topics: Adenosine; Animals; Biological Transport; Carrier Proteins; Cerebellum; Corpus Striatum; Down-Regulation; Gliosis; Heat-Shock Proteins; Hippocampus; Male; Methamphetamine; Microglia; Neurodegenerative Diseases; Radioligand Assay; Rats; Rats, Sprague-Dawley | 1998 |
Unravelling adenosine's effects on stroke.
Topics: Adenosine; Animals; Brain Ischemia; Gene Deletion; Glutamic Acid; Humans; Mice; Mice, Knockout; Neurodegenerative Diseases; Neuroprotective Agents; Phenotype; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2A; Receptors, Purinergic P1; Stroke | 2000 |
Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases.
Topics: Adenosine; Animals; Astrocytes; Brain Infarction; Brain Ischemia; Cell Death; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; Triazoles | 1999 |